The trial proceeded without reported toxicity, and no lethal dose threshold (LD1) was ever established in subsequent safety testing meaning researchers administering the compound could not find a dose that caused death in even 1% of test subjects across the animal model safety work that preceded and followed the human study
Training intensity must match current recovery capacity
Clinical trial results have shown remarkable weight loss outcomes, leading many experts to believe that Retatrutide could redefine how obesity is treated in the future
The differences between the two groups, however, were not statistically significant
Production of NAD+ declines sharply with age, leading to hidden cellular damage and visible symptoms like wrinkles, stubborn fat, cognitive fog, delayed recovery, and joint discomfort.[1][2][3] Emerging research suggests that this decline not only accelerates visible aging but also contributes to a cascade of metabolic and neurological issues, making NAD+ restoration a cornerstone of modern anti-aging protocols
See my creatine for women guide